Search results

Showing 1 - 8 of 8 results

AstraZenica CEO quits after drug sales slump

Quote of the day: 'After more than six years as chief executive officer of this great company I have decided that now is the right time to step down and allow a new leader to take the reins.' David Brennan has abruptly quit as AstraZenica chief exec after investors voiced their discontent in a boardroom...

US bosses slash and earn

Sack-happy US corporate bosses are supposedly being paid 42% more than their peers...

MT Leadership Visions: Adrian Fawcett, CEO of General Healthcare Group

The former Punch Taverns CEO on the need to balance efficiency with quality.

Hornby gets Boots after walking from HBOS

Alliance Boots has ruffled a few feathers by giving ex-HBOS chief Andy Hornby its top job.

A bitter pill for Glaxo

GlaxoSmithKline may have finally resolved its long-running succession problem, but new chief executive Andrew Witty will have some problems to address when he takes over next May.

Witty gets the nod at GSK

One of the longest-running succession battles in the corporate world came to an end on Monday, after unfancied Brit Andrew Witty was appointed chief executive of GlaxoSmithKline.

Too old to manage?

A considerable majority of the UK's senior managers are due to retire in the next three years, claims a new leadership report from the Hay Group this week. The report states that up to three-quarters of the country's senior executive managers will have collected the gold watch and donned their slippers...

Culitivate your supplier

Get to know the person as well as the product. Do they have kids? Where do they go on holiday?

Sort results by: date | relevance

Search filters:

By Channel

  • Leadership Remove filter

By Industry Sector

  • Pharmaceuticals & Biotechnology Remove filter

Click remove filters icon to remove filters

Clear this search

Add Search Filters:

By Date

By Publication

By Article Type


Additional Information